Document is current
Any future updates will be listed below
-
Authors
Nowicki, Katherine D. https://orcid.org/0000-0001-9661-0783
Rogers, Nathan D. https://orcid.org/0000-0002-3841-5602
Keeter, Carson L. https://orcid.org/0009-0001-2709-7338
Donaldson, Nathan J. https://orcid.org/0000-0001-6595-804X
Soep, Jennifer B. https://orcid.org/0009-0004-2346-741X
Zhao, Yongdong https://orcid.org/0000-0003-3618-1379
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 16 December 2024
First Online: 3 January 2025
Declarations
:
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of record of records, the Colorado Multiple Institutional Review Board (COMIRB) approved the collection of data for this study (#12–1557 and #13–0099). Informed consent and assent were obtained from all individual participants enrolled in this study after January 1, 2018 as data was collected prospectively (although prospective data was not included in this report), but consent was waived for those patients enrolled prior to January 1, 2018 given the retrospective nature of data collection for these patients.
: Not applicable.
: YD received research funding from Bristol-Myers Squibb, Rheumatology Research Foundation, Consortium for Technology & Innovation in Pediatrics, Childhood Arthritis & Rheumatology Research Alliance, royalties from UpToDate and consulting fees from Novartis in 2020.
